KEGG DRUG

Search results

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	Disease ID
1	ABP 959 - biosimilar to eculizumab (D03940)	[1] Eculizumab	[1] Eculizumab (D03940) 💬	[1] C5 💬	[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62 💬
2	ABP 959 - proposed biosimilar to eculizumab (D03940)	[1] Eculizumab	[1] Eculizumab (D03940) 💬	[1] C5 💬	[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62 💬
3	ECULIZUMAB (D03940)	[1] Eculizumab	[1] Eculizumab (D03940) 💬	[1] C5 💬	[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[7] 11, 13, 14, 61, 62, 109, 222 💬
4	SB12 (proposed eculizumab biosimilar) (D03940)	[1] Eculizumab	[1] Eculizumab (D03940) 💬	[1] C5 💬	[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62 💬
5	Soliris (eculizumab) (D03940)	[1] Eculizumab	[1] Eculizumab (D03940) 💬	[1] C5 💬	[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62 💬
6	Soliris ™ (eculizumab) (D03940)	[1] Eculizumab	[1] Eculizumab (D03940) 💬	[1] C5 💬	[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62 💬
7	SOLIRIS® (eculizumab) injection, for intravenous use (D03940)	[1] Eculizumab	[1] Eculizumab (D03940) 💬	[1] C5 💬	[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	[1] 62 💬